In that case: your company has invested heavily in developing an AIDS vaccine and wishes to embark on clinical trials. Commentary.
Evans
D
D
Bioethics Centre, University of Otago, New Zealand.
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D017954:Africa South of the Sahara; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000592:standards*; D019049:Developed Countries; D003906:Developing Countries; D026724:Ethical Review / Q000592:standards*; D006801:Humans; D038622:Internationality; D009042:Motivation; D035842:Research Subjects; D018570:Risk Assessment
D016915:AIDS Vaccines